Founder Profile

Stelios Karagiannoglou (BSc, MSc, MBA) is an accomplished Biopharma and Life Sciences executive, with a career spanning over three decades in the healthcare industry. He has extensive experience in managing commercial operations across various geographies and therapy areas and is highly regarded by his colleagues and partners for his strategic thinking and collaborative leadership style.

Stelios earned his BSc in Physics from Patras University in Greece, his MSc in Bioengineering from Strathclyde University in the UK, and his MBA from Henley Management College in the UK. He also completed training programs on Health Economics and Business Strategy. Stelios has presented at national medical conferences and is a published scientist in the field of bioengineering.

As an experienced Regional VP and General Manager, Stelios has achieved great success in launching new therapies and modalities in multiple geographies. He has successfully established affiliates in EMEA and has a proven track record of achieving innovative access solutions and partnerships with national healthcare systems. He has also served on the boards of industry associations and steering group committees of multi-stakeholder disease advocacy coalitions.

After a successful career at Gilead Sciences Inc, Stelios established his own consultancy, ExpandBio Ltd, to support the Biopharma industry in the EMEA region. He has an extensive network of collaborators who are experts in various fields within Biopharma, providing additional support to ExpandBio’s customers.

Stelios is passionate about the industry, patients, and science, and continues to make significant contributions through his work at ExpandBio Ltd.